Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zenas BioPharma (ZBIO) Assets Average (2024 - 2025)

Zenas BioPharma has reported Assets Average over the past 2 years, most recently at $352.8 million for Q4 2025.

  • Quarterly results put Assets Average at $352.8 million for Q4 2025, down 8.76% from a year ago — trailing twelve months through Dec 2025 was $352.8 million (down 8.76% YoY), and the annual figure for FY2025 was $376.8 million, up 72.0%.
  • Assets Average for Q4 2025 was $352.8 million at Zenas BioPharma, up from $307.6 million in the prior quarter.
  • Over the last five years, Assets Average for ZBIO hit a ceiling of $386.7 million in Q4 2024 and a floor of $307.6 million in Q3 2025.